Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Thye Lim

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Nature Communications|January 25, 2022
Misaligned sequencing reads from the GNAQ-pseudogene locus may yield GNAQ artefact variantsJing Quan Lim, Soon Thye Lim, Choon Kiat Ong
Leukemia & Lymphoma|January 19, 2008
Performance status is the single most important prognostic factor in lymphoma patients aged greater than 75 overriding other prognostic factors such as histologySoon Thye Lim, Siew Wan Hee, Richard Quek, et al.
Annals of Hematology|April 1, 2005
Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximabSoon Thye Lim, Nancy Rubin, Jonathan Said, et al.
Cancer|December 4, 2004
Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcomaSoon Thye Lim, Anil Tupule, Byron M Espina, et al.
Onkologie|March 4, 2006
Breast lymphoma: favorable prognosis after treatment with standard combination chemotherapySu-Pin Choo, Soon-Thye Lim, Ee-Hwee Wong, et al.
Journal of Hematology & Oncology|March 17, 2019
Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)Nagavalli Somasundaram, Jing Quan Lim, Choon Kiat Ong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapySoon-Thye Lim, Roksana Karim, Anil Tulpule, et al.
International Journal of Hematology|May 13, 2010
A prospective study to evaluate the feasibility and economic benefits of rapid infusion rituximab at an Asian cancer centerJoen Chiang, Alexandre Chan, Vivianne Shih, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 12, 2016
Incidence and Management of Toxicity Associated with LAsparaginase in the Treatment of ALL and NK/TCell Lymphoma: an Observational StudyShu Hui Yeang, Alexandre Chan, Chuen Wen Tan, et al.
Ejhaem|December 25, 2025
Real-World Insights Into the Clinical Characteristics and Survival Outcomes of Extranodal Peripheral T-Cell Lymphomas: A Multiethnic Asian Cohort StudyRyan Yee Shien Neo, Esther Wei Yin Chang, Soon Thye Lim, et al.
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Nature Communications|January 25, 2022
Misaligned sequencing reads from the GNAQ-pseudogene locus may yield GNAQ artefact variantsJing Quan Lim, Soon Thye Lim, Choon Kiat Ong
Leukemia & Lymphoma|January 19, 2008
Performance status is the single most important prognostic factor in lymphoma patients aged greater than 75 overriding other prognostic factors such as histologySoon Thye Lim, Siew Wan Hee, Richard Quek, et al.
Annals of Hematology|April 1, 2005
Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximabSoon Thye Lim, Nancy Rubin, Jonathan Said, et al.
Cancer|December 4, 2004
Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcomaSoon Thye Lim, Anil Tupule, Byron M Espina, et al.
Onkologie|March 4, 2006
Breast lymphoma: favorable prognosis after treatment with standard combination chemotherapySu-Pin Choo, Soon-Thye Lim, Ee-Hwee Wong, et al.
Journal of Hematology & Oncology|March 17, 2019
Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)Nagavalli Somasundaram, Jing Quan Lim, Choon Kiat Ong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapySoon-Thye Lim, Roksana Karim, Anil Tulpule, et al.
International Journal of Hematology|May 13, 2010
A prospective study to evaluate the feasibility and economic benefits of rapid infusion rituximab at an Asian cancer centerJoen Chiang, Alexandre Chan, Vivianne Shih, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 12, 2016
Incidence and Management of Toxicity Associated with LAsparaginase in the Treatment of ALL and NK/TCell Lymphoma: an Observational StudyShu Hui Yeang, Alexandre Chan, Chuen Wen Tan, et al.
Ejhaem|December 25, 2025
Real-World Insights Into the Clinical Characteristics and Survival Outcomes of Extranodal Peripheral T-Cell Lymphomas: A Multiethnic Asian Cohort StudyRyan Yee Shien Neo, Esther Wei Yin Chang, Soon Thye Lim, et al.
Pageof 19